Epitopea
Description: Epitopea develops cancer immunotherapies targeting hidden tumor-specific antigens from 'junk' DNA, using a proprietary multi-omics approach.
Country: UK
Based in: Cambridge
Founded: 2021
Funding Stage: Seed
Tags: ['Biotechnology', 'Life Science', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
